FDA 483 - Ximedica LLC - April 13, 2022

An FDA inspection of Ximedica LLC, a contract manufacturer in Providence, RI, identified a significant issue related to design validation. The firm failed to adequately validate a design using initial production units manufactured under defined operating conditions, indicating a lapse in quality system requirements. This single observation suggests a moderate severity finding concerning product development and manufacturing controls.